These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22629598)

  • 41. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.
    Galia E; Nicolaides E; Hörter D; Löbenberg R; Reppas C; Dressman JB
    Pharm Res; 1998 May; 15(5):698-705. PubMed ID: 9619777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects.
    Vertzoni M; Fotaki N; Kostewicz E; Stippler E; Leuner C; Nicolaides E; Dressman J; Reppas C
    J Pharm Pharmacol; 2004 Apr; 56(4):453-62. PubMed ID: 15099440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
    Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
    Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs.
    Prasad D; Gu CH; Kuldipkumar A
    Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
    Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
    Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioequivalence of two enteric coated formulations of pantoprazole in healthy volunteers under fasting and fed conditions.
    de Campos DR; Vieira NR; Bernasconi G; Barros FA; Meurer EC; Marchioretto MA; Coelho EC; Calafatti SA; Sommer C; Couto JM; Buranello S; Silva AR; Amarante AR; Abib E; Júnior JP
    Arzneimittelforschung; 2007; 57(6):309-14. PubMed ID: 17688075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is bicarbonate buffer suitable as a dissolution medium?
    Boni JE; Brickl RS; Dressman J
    J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms.
    Otsuka K; Shono Y; Dressman J
    J Pharm Pharmacol; 2013 Jul; 65(7):937-52. PubMed ID: 23738721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
    Pawar G; Wu F; Zhao L; Fang L; Burckart GJ; Feng K; Mousa YM; Al Shoyaib A; Jones MC; Batchelor HK
    AAPS J; 2023 Jun; 25(4):67. PubMed ID: 37386339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimer's Disease Prevention.
    Promzeleva M; Chislov M; Volkova T; Proshin A; Kumeev R; Terekhova I
    Chem Biodivers; 2018 Feb; 15(2):. PubMed ID: 29427367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
    Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
    Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states.
    Litou C; Patel N; Turner DB; Kostewicz E; Kuentz M; Box KJ; Dressman J
    Eur J Pharm Sci; 2019 Oct; 138():105031. PubMed ID: 31386891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media.
    Markopoulos C; Andreas CJ; Vertzoni M; Dressman J; Reppas C
    Eur J Pharm Biopharm; 2015 Jun; 93():173-82. PubMed ID: 25836053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
    Fagerberg JH; Sjögren E; Bergström CAS
    Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
    Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L
    Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 Jun; 10(6):2211-21. PubMed ID: 23654347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micelle dynamic simulation and physicochemical characterization of biorelevant media to reflect gastrointestinal environment in fasted and fed states.
    Xie X; Cardot JM; Garrait G; Thery V; El-Hajji M; Beyssac E
    Eur J Pharm Biopharm; 2014 Oct; 88(2):565-73. PubMed ID: 24954150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
    Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.